
Apogee Therapeutics, Inc.
APGE·NASDAQ
Last updated as of 2026-06-15 10:40 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
APGE stock price change
On the last trading day, APGE stock closed at 88.33 USD, with a price change of -1.31% for the day.
Trade spot stocks (24/7)Trending stocks
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn moreAPGE key data
Previous close88.33 USD
Market cap6.66B USD
Volume1.30M
P/E ratio-
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)-4.33 USD
Net income (FY)−255.84M USD
Revenue (FY)0.00 USD
Next report dateAug 17, 2026
EPS estimate-
Revenue estimate-
Shares float56.96M
Beta (1Y)0.04

Apogee Therapeutics, Inc. overview
Sector
Health technology
Industry
Biotechnology
CEO
Michael Henderson
Headquarters
Waltham
Website
apogeetherapeutics.com
Founded
2022
Employees (FY)
261
Change (1Y)
+65 +33.16%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
−980.24K USD
APGE stock price forecast
According to technical indicators for APGE stock, the price is likely to fluctuate within the range of 90.10–101.58 USD over the next week. Market analysts predict that the price of APGE stock will likely fluctuate within the range of 85.62–125.51 USD over the next months.
Based on 1-year price forecasts from 69 analysts, the highest estimate is 121.21 USD, while the lowest estimate is 77.85 USD.
For more information, please see the
APGE stock price forecast
page.
Latest APGE stock news
1 Stock to Watch & 1 to Avoid in a Challenging Glass Products Industry
Finviz2026-02-13 17:36:55
End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations
Finviz2026-02-19 00:42:11
Apogee Therapeutics to Participate in Upcoming March Conferences
Finviz2026-02-24 12:33:44
Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results
Finviz2026-03-02 12:03:46
Today's Bullish Patterns & Technical Sentiment | Published on 03/10: APGE, PTGX, BRZE and More
moomoo-证劵2026-03-10 12:48:55
Apogee Therapeutics announced that data results for part B of its APEX study, focusing on the 16-week induction period, are expected to be revealed in the second quarter of 2026.
老虎证券2026-03-23 10:49:59
Apogee Therapeutics, Inc. Announces Proposed $300 Million Underwritten Public Offering
Finviz2026-03-23 20:09:51
Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering
Finviz2026-03-25 01:58:01
1 Stock to Watch & 1 to Avoid in a Challenging Glass Products Industry
Finviz2026-02-13 17:36:55
End of Apogee (APGE) Drug Collaboration Leads to Revised Analyst Expectations
Finviz2026-02-19 00:42:11
Apogee Therapeutics to Participate in Upcoming March Conferences
Finviz2026-02-24 12:33:44
Apogee Therapeutics Provides Pipeline Progress and Reports Full Year 2025 Financial Results
Finviz2026-03-02 12:03:46
Today's Bullish Patterns & Technical Sentiment | Published on 03/10: APGE, PTGX, BRZE and More
moomoo-证劵2026-03-10 12:48:55
